Ineffectiveness of zinc gluconate nasal spray and zinc orotate lozenges in common-cold treatment: A double-blind, placebo-controlled clinical trial

Alternative Therapies in Health and Medicine

Volumn 12, Issue 1, 2006, Pages 34-38

  Eby, George A ^a   Halcomb, William W ^b  

^a George Eby Research   (United States)

^b William W Halcomb Clinic   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCONATE ZINC; PLACEBO; UNCLASSIFIED DRUG; ZINC DERIVATIVE; ZINC OROTATE;

ADOLESCENT; ADULT; AGED; ANOSMIA; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; COMMON COLD; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DISEASE ACTIVITY; DISEASE COURSE; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; HUMAN; MALE; MOUTH DISEASE; MOUTH ULCER; NAUSEA; NOSE IRRITATION; OLFACTORY SYSTEM; PAIN; TASTE DISORDER; TREATMENT OUTCOME; UNITED STATES; VOMITING;

ADMINISTRATION, INTRANASAL; ADOLESCENT; ADULT; ANTI-INFECTIVE AGENTS, LOCAL; CHI-SQUARE DISTRIBUTION; COMMON COLD; COUGH; DOUBLE-BLIND METHOD; FEMALE; GLUCONATES; HUMANS; MALE; MIDDLE AGED; SEVERITY OF ILLNESS INDEX; TABLETS; TIME FACTORS; TREATMENT OUTCOME; ZINC;

EID: 30744434617     PISSN: 10786791     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Eby GA, Davis DR, Halcomb WW. Reduction in duration of common colds by zinc gluconate lozenges in a double-blind study. Antimicrob Agents Chemother. 1984;25:20-24.
2. Eby GA. Zinc Lozenges: cold cure or candy? Solution chemistry determinations. Biosci Rep. 2004;24:23-39.
3. Gwaltney JM Jr. Rhinovirus. In: Mandell GL et al, eds. Principles and Practices of Infectious Diseases. New York, NY: John Wiley & Sons, Inc; 1979;1124-1134.
4. Korant BD, Kaurer JC, Butterworth BE. Zinc ions inhibit replication of rhinoviruses. Nature. 1974;248:588-590.
5. Tucci ER, Ke CH, Li NC. Linear free energy relationships for proton dissociation and metal complexation of pyrimidine acids. J Inorg Nucl Chem. 1967;29:1657.
6. O'Dell BL. Personal reflections on a galvanizing trail. Anna Rev Nutr. 1998;18:1-18.
7. Shankar AH, Prasad AS. Zinc and immune function: the biological basis of altered resistance to infection. Am J Clin Nutr. 1998;68(suppl):447S-463S.
8. Pasternak CA. Virus, toxin, complement: common actions and their prevention by Ca2+ or Zn2+. Bio Essays. 1987;6:14-19.
9. Eby GA, Halcomb WW. High-dose zinc to terminate angina pectoris: a review and hypothesis for action by ICAM inhibition. Med Hypotheses. 2005;66:169-172.
10. Hirt M, Nobel S, Barron E. Zinc nasal gel for the treatment of common cold symptoms: 3 double-blind, placebo-controlled trial. Ear Nose Throat J. 2000;79:778-780, 782.
11. Turner RB. Ineffectiveness of intranasal zinc gluconate for prevention of experimental rhinovirus colds. Clin Infect Dis. 2001;33:1865-1870.
12. Mossad SB. Effect of zincum gluconicum nasal gel on the duration and symptom severity of the common cold in otherwise healthy adults. QJM. 2003;96:35-43.
13. Belongia EA, Berg R, Liu K. A randomized trial of zinc nasal spray for the treatment of upper respiratory illness in adults. Am J Med. 2001;111:103-8.
14. Gutman J. Modern Drug Encyclopedia and Therapeutic Guide. New York: New Modern Drugs; 1941.
15. Merck. Part II, Formulas. In: Merck's 1901 Manual of the Materia Medica. New York: Merck and Co; 1901:125.
16. Merck. Remedies for nasal catarrh. In: Merck's Manual of the Materia Medica. New York: Merck and Co; 1923:160.
17. Petrus EJ, Lawson KA, Bucci LR, et al. Randomized, double-masked, placebo-controlled, clinical study of the effectiveness of zinc acetate lozenges on common cold symptoms in allergy-tested subjects. Curr Ther Res Clin Exp. 1998;59:595-607.
18. Al-Nakib W, Higgins PG, Barrow I, Batstone G, Tyrell DA. Prophylaxis and treatment of rhinovirus colds with zinc giuconate lozenges. J Antimicrob Chemother. 1987;20:893-901.
19. Nordenström BE. Biologically closed electric circuits. Clinical, experimental and theoretical evidence for an additional circulatory system. Stockholm: Nordic Medical Publications; 1983:112-172.
20. Sunderman FW Jr. Nasal toxicity, carcinogenicity, and olfactory uptake of metals. Ann Clin Lab Sci. 2001;31:3-24.
21. Tisdall FF, Brown A, Defries RD. Persistent anosmia following zinc sulfate nasal spraying. J Ped. 1938;13:60-62.
22. Schultz EW, Gebhardt LP. Zinc sulfate solution for the prevention of poliomyelitis in man. JAMA. 1938;110:2024.
23. Slotnick B, Glover P, Bodyak N. Does intranasal application of zinc sulfate produce anosmia in the rat? Behav Neurosci. 2000;114:814-829.
24. Houpt KA, Davis PP, Hintz HF. Effect of peripheral anosmia in dogs trained as flavor validators. Am J Vet Res. 1982;43:841-843.
25. Booth KK, Katz LS. Role of the vomeronasal organ in neonatal offspring recognition in sheep. Biol Reprod. 2000;63:953-958.
26. Bonadonna F, Bretagnolle V. Smelling home: a good solution for burrow-finding in nocturnal petrels? J Exp Biol. 2002;205:2519-2523.
27. 4 and other chemicals. Tissue Cell. 1982;14:717-733.
28. DeCook CA, Hirsch AR. Anosmia due to inhalational zinc: a case report. Chem Senses. 2000;5:659.
29. Jafek BW, Linschoten MR, Murrow BW. Anosmia after intranasal zinc gluconate use. Am J Rhinol. 2004;18:137-141.
30. Cannan RK, Kibrick A. Complex formation between carboxylic acids and divalent metal cations. J Am Chem Soc. 1938;60:2314-2320.
31. Owen BB, Gurry RW. The electrolytic conductivity of zinc sulfate and copper sulfate in water at 25°. J Am Chem Soc. 1938;60:3074-3078.